Hybrid Nanoparticle Pyramids for Intracellular Dual MicroRNAs Biosensing and Bioimaging.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28221715.
- Also identified by DOI 10.1002/adma.201606086.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study strategically fabricates multifunctional nanopyramids to allow the ultrasensitive quantification of dual microRNAs (miR-203<sup>b</sup> and miR-21) in living cells and their responsive bioimaging in vivo. The nanopyramids, composed of Au-Cu<sub>9</sub> S<sub>5</sub> nanoparticles (NPs), upconversion NPs (UCNPs), and Ag<sub>2</sub> S NPs, emit two luminescent signals simultaneously with excitation at 808 nm, arising from the UCNPs at 541 nm in the visible region and from the Ag<sub>2</sub> S NPs at 1227 nm in the second window of near-infrared (NIR-II) region. The upconversion luminescence has a linear relationship with miR-203<sup>b</sup> from 0.13 to 54.54 fmol per 10 µg<sub>RNA</sub> and a limit of detection (LOD) of 0.09 fmol per 10 µg<sub>RNA</sub> , whereas the Ag<sub>2</sub> S NP luminescence has a linear relationship with miR-21 from 0.37 to 43.56 fmol per 10 µg<sub>RNA</sub> , with a LOD of 0.23 fmol per 10 µg<sub>RNA</sub> . Significantly, this study demonstrates that the nanopyramids can be successfully used for miRs-responsive bioimaging in a tumor-bearing animal model. Furthermore, taking advantage of the photothermal capabilities of pyramids, the tumors can also be eliminated completely. These nanopyramids not only overcome the obstacles in the simultaneous detection of multiple miRs at the cellular level but also provide a cancer theranostic platform in vivo.
Medical subject headings
- Nanoparticles